[
balram bhargava news
]Latest from balram bhargava
‘Major safety concerns’: ICMR chief's advice for using Molnupiravir
The Drug Controller General of India (DCGI) last week gave emergency approval to Molnupiravir as the country witnessed a spike in Covid-19 cases following the emergence of the highly contagious Omicron variant.
Published on Jan 05, 2022 06:16 PM IST
hindustantimes.com | Written by Kunal Gaurav
ICMR chief lists dos and don’ts during Christmas, New Year amid Omicron
ICMR director general Balram Bhargava said districts reporting more than 5 per cent of weekly Covid-19 test positivity rate must implement strict measures for at least two weeks until it comes down.
Published on Dec 17, 2021 06:06 PM IST
Written by Sharangee Dutta | Edited by Meenakshi Ray, Hindustan Times, New Delhi
Don’t delay getting fully vaccinated: Centre after Omicron cases found in India
India has now become the 30th country to have confirmed the presence of Omicron Covid-19 variant, after two males aged 66 and 46, were found positive with the strain of the virus in Karnataka.
Updated on Dec 02, 2021 11:23 PM IST
Written by Sharangee Dutta | Edited by Avik Roy, Hindustan Times, New Delhi
Need more data to begin Covid-19 vaccination for children at large: ICMR DG
Addressing a press conference on Friday, ICMR DG Dr Balram Bhargava said that a small study has been started for vaccinating children who are between 2-18 years old. The result of this study, Bhargava said, would be out by September.
Updated on Jun 25, 2021 06:27 PM IST
hindustantimes.com | Written by Karan Manral | Edited by Poulomi Ghosh, New Delhi
'Will have enough vaccines by July to inoculate 1 cr people a day': ICMR chief
The ICMR chief's comments come in the wake of demands made by several health experts that vaccination needs to be scaled up in India. Several states too have complained about vaccine shortage, and a few of them even floated global tenders to directly get the supply.
Published on Jun 01, 2021 06:21 PM IST
hindustantimes.com | Edited by Amit Chaturvedi, Hindustan Times, New Delhi
India's Covid-19 vaccines will be effective against new variants, says ICMR
Dr Balram Bhargava, Director General of ICMR, said a paper on Covaxin's neutralisation potential against the UK strain has been accepted for publication.
Published on Feb 19, 2021 10:16 AM IST
ANI | , Thiruvananthapuram
‘Bharat Biotech vaccine approved in clinical trial mode, consent of participants has to be taken’: ICMR
Industry experts and some opposition leaders have expressed concern over the absence of Phase 3 trial data on Covaxin.
Updated on Jan 06, 2021 10:17 AM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by: Amit Chaturvedi
‘Will take that vaccine...’: Experts explain why Bharat Biotech’s vaccine got approval
Government experts on Tuesday clarified why Covaxin has been given the nod for restricted emergency use.
Updated on Jan 05, 2021 09:38 PM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Poulomi Ghosh
‘2 vaccines a result proactive approach,’ says DG-ICMR
“These kinds of approvals are purely data-driven, and in both these vaccines Phase 2 immunogenicity has been well established. The question of approving a vaccine without adequate data does not arise as the expert panel minutely scans the national as well international data presented to them before granting an approval,” said DG-ICMR.
Updated on Jan 04, 2021 05:48 AM IST
Hindustan Times, New Delhi | Rhythma Kaul
Bharat Biotech vaccine more likely to work against newer strains like UK variant: Vardhan
India’s drugs regulator on Sunday approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
Updated on Jan 04, 2021 12:08 AM IST
New Delhi | Press Trust of India | Posted by Kanishka Sarkar
‘Bharat Biotech vaccine may have some advantages...’: ICMR chief on Covaxin, mutant strain
Covaxin is a whole virion inactivated Covid-19 vaccine while Oxford vaccine works differently — it produces surface spike protein priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.
Updated on Jan 03, 2021 08:16 PM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Poulomi Ghosh
Experimental therapies not to be used indiscriminately, warns ICMR
The warning comes in the backdrop of the discovery in the UK of a new variant of the virus that causes Covid-19. The new strain, scientists say, is more transmissible than the original one.
Updated on Dec 30, 2020 01:59 AM IST
Hindustan Times, New Delhi | Rhythma Kaul
Non-judicious use of therapies for Covid-19 leads to virus mutations: ICMR chief
“Those therapies which are being touted as ‘anti-viral’ or ‘anti-COVID therapies’ and they have do not have benefits established in a scientific research paper, those therapies should not be used as they will put tremendous immune pressure on the virus and it will tend to mutate more, Dr Bhargava told ANI.
Published on Dec 29, 2020 09:03 PM IST
New Delhi | Asian News International | Posted by Srivatsan K C
ICMR chief Balram Bhargava admitted to AIIMS Trauma Centre for Covid-19 treatment
Bhargava, who was admitted to the AIIMS Trauma Centre, is recovering well and likely to be discharged soon, the report added.
Updated on Dec 18, 2020 10:40 PM IST
Hindustan Times, New DElhi | hindustantimes.com | Edited by Arpan Rai
‘Need to follow Covid-19 protocol even after vaccine is available, masks here to stay’: ICMR chief
Speaking at a webinar hosted by Lucknow’s King George’s Medical University on Saturday, professor Balram Bhargava said that India is making rapid progress as far as the development of Covid-19 vaccine is concerned.
Updated on Nov 29, 2020 09:10 AM IST
HIndustan Times, New Delhi | hindustantimes.com | Edited by: Amit Chaturvedi
Delhi health minister Satyendar Jain bats for plasma therapy
ICMR had conducted a pan-India study to determine the role of plasma therapy, and the Union health ministry had added it as one of the investigational therapies in the national protocol for treating Covid-19 patients.
Updated on Oct 22, 2020 06:41 AM IST
Hindustan Times, New Delhi | Anonna Dutt
Plasma therapy may not be used on patients
ICMR had conducted a pan-India study to determine the role of plasma therapy, and the Union health ministry had added it as one of the investigational therapies in the national protocol for treating Covid-19 patients.
Updated on Oct 21, 2020 02:33 AM IST
Hindustan Times | Rhythma Kaul, New Delhi
30 million frontline workers to get Covid-19 vaccine in phase 1
The 30 million include 7 million doctors and paramedics, in addition to 20 million other frontline health workers, Union health secretary Rajesh Bhushan said on the sidelines of a Covid-19 media briefing on Tuesday.
Updated on Oct 21, 2020 01:35 AM IST
Hindustan Times, New Delhi | Rhythma Kaul
ICMR DG hails Gandhian perspective of healthy living in Covid-19 times
he ICMR Director-General opined that Gandhi was aware and concerned about individual health and poured his thoughts in the book “Key to Health”.
Updated on Oct 03, 2020 10:13 AM IST
New Delhi | Asian News International | Posted by Kanishka Sarkar
Covid-19: Key highlights of second sero-survey findings
As per the findings, a considerable population still vulnerable to Covid-19 which has killed over 96,300 people across the country.
Updated on Sep 29, 2020 07:40 PM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Shivani Kumar
Delhi LG asks expert panel to suggest measures to tackle Covid-19 situation: Report
Delhi recorded 4,071 cases on September 19; 4,127 on September 18; 4,432 on September 17; 4,473 on September 16 and 4,263 on September 15.
Published on Sep 22, 2020 06:33 PM IST
New Delhi | Press Trust of India | Posted by Kanishka Sarkar
India’s Covid-19 recovery rate surges past 78%, one of the highest globally: Govt
As of Tuesday, 3,859,399 people had recovered from Covid-19 and the country’s recovery tally exceeded the active cases by 2,869,338.
Updated on Sep 15, 2020 10:25 PM IST
Hindustan Times, New Delhi | hindustantimes.com| Edited by Kanishka Sarkar
Covid-19: The daredevils who defy scientific advice
Many continue to go about their lives, refusing to follow simple preventive health guidelines, as if the world is already in a post-pandemic era
Updated on Aug 30, 2020 09:14 PM IST
Payal S Kapoor
Clinical study of Covid-19 vaccine on human volunteers now in India
Two pharmaceutical companies are carrying out clinical studies on approximately 1,000 human volunteers each at different sites.
Updated on Jul 14, 2020 06:38 PM IST
Hindustan Times, New Delhi | hindustantime.com| Edited by Sabir Hussain
The intersection of politics and science, writes Chanakya
The two most powerful tools in any country’s armoury, when it comes to fighting the Covid-19 pandemic, are data and science, and political leaders through the centuries have had an uncomfortable relationship with both.
WHO approves India’s cost-effective TB test
The WHO’’s Global TB Programme has included TrueNat TB test, a new molecular test that detects TB as well as resistance to the drug Rifampicin in about 90 minutes, in its rapid communication document on molecular investigative procedure in laboratory medicine and pharmacology.
Updated on Jan 17, 2020 12:37 AM IST
Hindustan Times, New Delhi | HT Correspondent
National Aids Research Institute to drop focus on HIV, undergo name change
NARI director Dr Samiran Panda said in an interview that this was among the issues discussed during the February 8 visit by ICMR (Indian Council of Medical Research) director Dr Balram Bhargava to the institute at Bhosari, Pune.
Updated on Feb 17, 2019 07:45 AM IST
Pune | Nozia Sayyed